Cemented vs Non-cemented Semiendoprosthesis in the Treatment of Proximal Femoral Fractures

Kuopio University Hospital400 enrolled

Overview

The hip semiendoprosthesis is an acceptable method to treat the proximal femoral fractures. Traditionally, the cemented version of the semiendoprosthesis has been used for this indication. However, the cementing carries a risk of fat embolism during the pressurization of the cement. The fat embolism can be avoided when using the non-cemented semiendoprosthesis. In this study we want to find out whether there are any differences in the treatment results between the cemented and non-cemented semiendoprostheses when treating the proximal femoral fractures.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

400

Conditions

Hip Fracture Proximal Femoral Fracture

Interventions

Application of a cemented semiendoprosthesis (Basis, Smith \& Nephew)

non-cementedDEVICE

Patients are treated with a non-cemented semiendoprosthesis (Biomet Taperloc, Biomet Inc.)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * A proximal femoral fracture Exclusion Criteria: * Rheumatoid arthritis * Pathologic fracture * Severe dementia (preventing the informed consent)

Locations (2)

Central Hospital of North Carelia

Joensuu, Finland

Kuopio University Hospital

Kuopio, Finland

Outcomes

Primary Outcomes

Primary mortality

Time frame: 3 months

Secondary Outcomes

Prosthetic complications

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.